Moderna shares pace toward their highest close since late 2024 after unveiling a new cell therapy program.
Moderna shares are set for their highest close since late 2024, experiencing a significant uptrend. This notable performance follows the company's recent announcement regarding a new cell therapy program. The innovative development has positively impacted investor sentiment and…
Market Samachar is a news aggregator. This article was originally published by Barron's. Tap the button above to read the full story on their site.